Alpha Teknova, Inc.

Life-science reagents/tools company with operating losses and cash burn, funded.

Strengths

• Strong liquidity — current ratio 4.6 (87th)

Risks

• Operating/net losses — operating margin -42%, net margin -43%
• Cash burn — FCF -$10M
• Tools-demand softness/scale risk — per 10-K

Notable findings

• Restatement▪ The terms of our Second Amended and Restated Credit Agreement entered into on March 3, 2025, may restrict our current and future operations, particularly our ability to respond to changes or to take 8-K ↗
• Net lossNet loss (net margin -42.6%)
• Cash burnNegative free cash flow (-9.8M)
• Material weakness▪ Material weaknesses in our internal control over financial reporting may cause us to fail to timely and accurately report our financial results or result in a material misstatement of our financial
• Chronic dilutionShare count +87%/yr over 4y (dilution, book value/share -96%)
• Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
• Exec changeRecent 8-K item 5.02 8-K ↗
• Insider buyingInsider buying — 2 open-market buy(s) by 2 insider(s) (cluster of 2 insiders, ~$143,417, last 6mo) Form 4 ↗
• Notable holderHeld by 4 notable fund(s): STATE STREET CORP, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC +1 more (as of 2026-03-31)